Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Cell surface levels of endothelial ICAM-1 influence thetranscellular or paracellularT-celldiapedesis across the blood-brain barrier.
Sexuality and multiple sclerosis.
Evaluation of Focal Cervical Spinal Cord Lesions in Multiple Sclerosis: Comparison of White Matter-Suppressed T1 Inversion Recovery Sequence versus Conventional STIR and Proton Density-Weighted Turbo Spin-Echo Sequences.
Employment and multiple sclerosis in new zealand.
Over the past decade, we have made great advances in the field of multiple sclerosis. Introduction.
Cuprizone does not induce CNS demyelination in nonhuman primates.
A 3meter Timed Tandem Walk is an early marker of motor and cerebellar impairment in fully ambulatory MS patients.
Cell type- and brain region-resolved mouse brain proteome.
CRISPR/Cas9 System as an Agent for Eliminating Polyomavirus JC Infection.
Aging of the cingulum in the human brain: Preliminary study of a diffusion tensor imaging study.
The Association of Vitamin D Receptor Polymorphisms with Multiple Sclerosis in a Case-Control Study from Kuwait.
Predicting relapsing-remitting dynamics in multiple sclerosis using discrete distribution models: a population approach.
Role of high mobility group box protein 1 (HMGB1) in peripheral blood from patients with multiple sclerosis.
Treatment with Anti-EGF Ab Ameliorates Experimental Autoimmune Encephalomyelitis via Induction of Neurogenesis and Oligodendrogenesis.
The common marmoset as an indispensable animal model for immunotherapy development in multiple sclerosis.
Effects of intraventricular methotrexate administration on Cuprizone-induced demyelination in mice.
A serial 10-year follow-up study of brain atrophy and disability progression in RRMS patients.
Sleep disorders in multiple sclerosis in china: clinical, polysomnography study, and review of the literature.
Patient expectations and experiences of multiple sclerosis interferon β-1a treatment: a longitudinal, observational study in routine UK clinical practice.
Reply to comments on the review article 'Time trends in the incidence and prevalence of multiple sclerosis in Norway during eight decades'.
Olfactory dysfunction in patients with neuromyelitis optica.
Altered expression of myelin-associated inhibitors and their receptors after traumatic brain injury in the mouse.
Evidence-based guideline: Intravenous immunoglobulin in the treatment of neuromuscular disorders: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.
Laquinimod, an upcoming oral immunomodulatory agent for treatment of multiple sclerosis.
Immune-Modulation and Properties of Absorption and Blood Brain Barrier Permeability of 1,8-Naphthyridine Derivatives.

Pages